KIRA6 Restrains the Generation of Myeloid-Derived Suppressor Cells and Overcomes Resistance to Anti-PD-1 Therapy

Researchers evaluated the potential of KIRA6, an inhibitor for inositol-requiring enzyme 1α kinase activity and RNase activity, to abrogate myeloid-derived suppressor cell-mediated immune suppression.